N. Weigert et al., FUNCTIONAL-CHARACTERIZATION OF A MUSCARINIC RECEPTOR STIMULATING GASTRIN-RELEASE FROM RABBIT ANTRAL G-CELLS IN PRIMARY CULTURE, European journal of pharmacology, 264(3), 1994, pp. 337-344
In previous studies carbachol-induced stimulation of gastrin release f
rom antral G-cells in primary culture suggested the presence of muscar
inic acetylcholine receptors on this cell type. Therefore, we attempte
d to pharmacologically characterize the muscarinic acetylcholine recep
tor subtype involved. Enzymatically isolated rabbit antral mucosal cel
ls (0.8% G-cells) were separated by counterflow elutriation yielding a
fraction (1.7% G-cells) that was placed in culture on collagen-coated
well plates. After 24-36 h of culture 13.0 +/- 2.4% of total adherent
cells were immunoreactive for gastrin as shown by immunocytochemical
staining using the avidin-biotin complex method. In this preparation b
asal gastrin release ranged from 3.3 +/- 0.3 to 4.1 +/- 0.3% of total
cellular content. Maximal gastrin release in response to the acetylcho
line receptor agonist carbachol (10(-4) M) or the selective muscarinic
receptor agonist arecaidine propargyl ester (10(-4) M) was 8.5 +/- 0.
4% and 7.6 +/- 0.4% of total cellular content, respectively. The EC(50
) values were 3.7 +/- 0.5 X 10(-6) M carbachol and 1.8 +/- 0.4 X 10(-6
) M arecaidine propargyl ester. At a concentration of 10(-6) M the non
-selective muscarinic receptor antagonist atropine and the muscarinic
M(3) receptor preferring antagonist hexahydro-sila-difenidol (HHSiD; M
(3) greater than or equal to M(1) > M(2)) completely inhibited gastrin
release in response to carbachol (K-i values: 52 X 10(-9) M atropine
and 29 X 10(-9) M HHSiD) and arecaidine propargyl ester (K-i values: 1
1 X 10(-9) M atropine and 13 X 10(-9) M HHSiD). In contrast the muscar
inic M(1) receptor preferring antagonist pirenzepine (M(1) > M31 M(2))
even at high concentrations (10(-6)-10(-5) M) inhibited the carbachol
- and arecaidine propargyl ester-induced gastrin release by only about
40%, while the muscarinic M(2)/M(4) receptor antagonist 1-dihydro-6H-
pyrido[2,3-b][1,4]benzodiazepin-6-one hydrochloride (AQ-RA 741; M(2) =
M(4) > M(1) > M(3)) was ineffective at all concentrations tested (10(
-9)-10(-5) M). We conclude that muscarinic receptor agents may directl
y stimulate gastrin release from antral G-cells via activation of musc
arinic M(3) receptors most probably residing on the G-cells themselves
.